CD200 R1

CD200 R1 詳細

英語名Cell surface glycoprotein CD200 receptor 1市販薬剤の数0
治験薬の数4ターゲットの別称Cell surface glycoprotein OX2 receptor 1,CD200 cell surface glycoprotein receptor,CD200R
研究&開発段階Phase 2 Clinical
英語名Cell surface glycoprotein CD200 receptor 1
ターゲットの別称Cell surface glycoprotein OX2 receptor 1,CD200 cell surface glycoprotein receptor,CD200R
市販薬剤の数0
治験薬の数4
研究&開発段階Phase 2 Clinical

CD200 R1 製品リスト

  • 属性

    Protein (2)

  • 製品ライブラリ

    オンライン (2)

  • Human (2)

  • タグ

    Fc Tag & Avi Tag (1)His Tag (1)

  • マーカー

    Biotin-labeled (1)Unconjugated (1)

製品番号発現システム製品説明タンパク質の構造純度特性
CR2-H52H6
Human
HEK293
Human CD200 R1 / CRTR2 Protein, His Tag, low endotoxin (MALS verified)
CR2-H82F4
Human
HEK293
Biotinylated Human CD200 R1 / CRTR2 Protein, Fc,Avitag™
総数量2
  • 1

CD200 R1バックグランド

Cell surface glycoprotein CD200 receptor 1 is a protein that in humans is encoded by the CD200R1 gene. This gene encodes a receptor for the OX-2 membrane glycoprotein. Both the receptor and substrate are cell surface glycoproteins containing two immunoglobulin-like domains. This receptor is restricted to the surfaces of myeloid lineage cells and the receptor-substrate interaction may function as a myeloid downregulatory signal. CD200 and its receptor CD200R are both type-1 membrane glycoproteins, which are members of the immunoglobulin superfamily (IgSF). Besides the inhibitory effect on macrophages, CD200/CD200R also play an important role in regulating the regulatory T cells, allergicreaction, autoimmune diseases, allograft, neurological diseases and other autoimmune-related diseases. The interaction between CD200, which is mainly present in neurons but also in astrocytes, and CD200R1, which is mainly present in microglia, is one of the mechanisms involved in keeping the microglial proinflammatory phenotype under control in physiological conditions. Alterations in the expression of CD200 and CD200R1 have been described in neurodegenerative diseases, but little is known about the mechanism of regulation of these proteins under physiological or pathological conditions.

CD200 R1分子の別称

CD200R,CRTR2,MOX2R,OX2R

ライセンシング

プロジェクト薬物タイプ治療分野適応症ステージエリア
High selective OX1R/OX2R dual inhibitor treating insomniaSmall moleculeNeurological diseaseInsomniaPhase IGlobal

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
P-00623ME-00610; P-006; 23ME’610Phase 2 Clinical23andme IncCarcinoma, Ovarian Epithelial; Carcinoma, Renal Cell; Fallopian Tube Neoplasms; Microsatellite instability-high cancer; Neuroendocrine Tumors; Peritoneal Neoplasms; Small Cell Lung Carcinoma; Solid tumours
詳細
GS-5305GS-5305Phase 1 ClinicalGilead Sciences LdaInflammation
詳細
DS-234DS-234; ARQ-234Phase 1 ClinicalDucentis BioTherapeutics LtdDermatitis, Atopic; Eczema
詳細
UcenprubartLY-3454738Phase 1 ClinicalEli Lilly And CompanyChronic Urticaria; Dermatitis, Atopic
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8